Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Objective: To determine the association between features of the insulin resistance syndrome and Alzheimer's disease. Design: Cross sectional population based study. Subjects: 980 people aged 69 to 78 (349 men, 631 women). Setting: Population of Kuopio, eastern Finland. Main outcome measures: Presence of features of the insulin resistance syndrome and diagnosis of Alzheimer's disease by detailed neurological and neuropsychological evaluation. Results: 46 (4.7%) subjects were classified as having probable or possible Alzheimer's disease. In univariate analyses, apolipoprotein E4 phenotype (odds ratio; 95% confidence interval 3.24: 1.77 to 5.92), age (1.16; 1.05 to 1.29), low level of education (0.82; 0.72 to 0.93), low total cholesterol concentration (0.77; 0.59 to 1.00), high systolic blood pressure (1.01; 1.00 to 1.03), high fasting and 2 hour plasma glucose concentrations (1.11; 1.01 to 1.23 and 1.08; 1.03 to 1.13, respectively), high fasting and 2 hour insulin concentrations (1.05; 1.02 to 1.08 and 1.003; 1.00 to 1.01, respectively), and abnormal glucose tolerance (1.86; 1.23 to 2.80) were significantly associated with Alzheimer's disease. In multivariate analysis including apolipoprotein E4 phenotype, age, education, systolic blood pressure, total cholesterol concentration, fasting glucose concentration, and insulin concentration, apolipoprotein E4 phenotype, age, education, total cholesterol, and insulin were significantly associated with Alzheimer's disease. In 532 non-diabetic subjects without the e4 allele hyperinsulinaemia was associated with an increased risk for Alzheimer's disease (prevalence of disease 7.5% v 1.4% in normoinsulinaemic subjects, P=0.0004). In contrast, in the 228 with the e4 allele hyperinsulinaemia had no effect on the risk of disease (7.0% v 7.1%, respectively). Conclusion: Features of the insulin resistance syndrome are associated with Alzheimer's disease independently of apolipoprotein E4 phenotype. Key messages: Apolipoprotein E4 phenotype is a risk factor for Alzheimer's disease Other risk factors for Alzheimer's disease are not well documented in previous studies In this study, hyperinsulinaemia and other features of the insulin resistance syndrome were associated with Alzheimer's disease Insulin resistance is affected by modifications in lifestyle, so the risk of Alzheimer's disease might be reducible by the same measures
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Immunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
Diagnostic and Statistical Manual of Mental Disorder
Ellsworth, P. D. (1980) · The American Journal of Occupational Therapy · doi:10.5014/ajot.34.12.819a · Cited by 1,700
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062
Screening for dementia by memory testing
Grober, E., Buschke, H., Crystal, H., Bang, S., & Dresner, R. (1988) · Neurology · doi:10.1212/wnl.38.6.900 · Cited by 961
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · cited 1×
“are found in amyloid plaques of Alzheimer's disease.”
BackgroundHow good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Self-citationPrineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Association of diabetes mellitus and dementia, the Rotterdam study
Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F., Grobbee, D. E., & Breteler, M. M. B. (1996) · Diabetologia · doi:10.1007/s001250050588 · Cited by 677
NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.8.960 · Cited by 591
Self-citationBaura, G. D., Foster, D. M., Porte, D., Kahn, S. E., Bergman, R. N., Cobelli, C., & Schwartz, M. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116773 · Cited by 489 · cited 1×
“Insulin is transported to cerebrospinal fluid and also synthesised in the brain, where it acts as a neuromodulator regulating energy balance.”
BackgroundEhnholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 405
Jarvik, G. P., Wijsman, E. M., Kukull, W. A., Schellenberg, G. D., Yu, C., & Larson, E. B. (1995) · Neurology · doi:10.1212/wnl.45.6.1092 · Cited by 370
Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D., & Dorsa, D. M. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002003 · Cited by 344
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., & DeKosky, S. T. (1995) · Nature Genetics · doi:10.1038/ng0895-486 · Cited by 336
DRAWING DISABILITY IN RELATION TO LATERALITY OF CEREBRAL LESION
WARRINGTON, E. K., JAMES, M., & KINSBOURNE, M. (1966) · Brain · doi:10.1093/brain/89.1.53 · Cited by 249
Asymptomatic atherosclerosis and insulin resistance.
Laakso, M., Sarlund, H., Salonen, R., Suhonen, M., Pyörälä, K., Salonen, J. T., & Karhapää, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1068 · Cited by 206
Self-citationKuusisto, J., Koivisto, K., Kervinen, K., Mykkanen, L., Helkala, E.-L., Vanhanen, M., Hanninen, T., Pyorala, K., Kesaniemi, Y. A., Riekkinen, P., et al. (1994) · BMJ · doi:10.1136/bmj.309.6955.636 · Cited by 204
Self-citationApolipoprotein E phenotyping from serum by Western blotting
Menzel, H., & Utermann, G. (1986) · ELECTROPHORESIS · doi:10.1002/elps.1150071103 · Cited by 175
MRCPsych, M. P., FRANZCP, M. C., & Mann, A. (1994) · Neurology · doi:10.1212/wnl.44.1.97 · Cited by 163
Essential hypertension and cognitive function. The role of hyperinsulinemia.
Kuusisto, J., Koivisto, K., Mykkänen, L., Helkala, E. L., Vanhanen, M., Hänninen, T., Pyörälä, K., Riekkinen, P., & Laakso, M. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.771 · Cited by 120
Self-citationLANDIN, K., BLENNOW, K., WALLIN, A., & GOTTFRIES, C. ‐. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00684.x · Cited by 112
Mykkänen, L., Laakso, M., Uusitupa, M., & Pyörälä, K. (1990) · Diabetes Care · doi:10.2337/diacare.13.11.1099 · Cited by 110
Self-citationIMMUNOASSAY OF INSULIN WITH INSULIN ANTIBODY PRECIPITATE
Stimmler, L. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91306-0 · Cited by 98
Weiss, W., & Weinfeld, F. D. (1979) · PubMed · Cited by 94
Palomäki, P., Miettinen, H., Mustaniemi, H., Lehto, S., Pyör←ä, K., Mähönen, M., & Tuomilehto, J. O. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90213-5 · Cited by 60
Koivisto, K. J., Helkala, E., Reinikainen, K. J., Hänninen, T., Mykkänen, L. M., Laakso, M., Pyörärälä, K., & Riekkinen, P. J. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500306 · Cited by 46
Self-citationPeripheral glucose metabolism and insulin sensitivity in Alzheimer's disease
Kilander, L., Boberg, M., & Lithell, H. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb05511.x · Cited by 30
Cited by
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
“A more accurate term, in our view, is insulinresistant brain state (12), a neural variant of the insulin resistance syndrome (154) that was previously identified as a feature of several disorders, most notably T2D (1,2), the metabolic syndrome (155), and AD itself (12, 21, 34, 156).”
BackgroundObesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291
Self-citationType 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Metadata
- Authors
- Kuusisto, J., Koivisto, K., Mykkänen, L., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1997-10-25
- Volume
- 315
- Issue
- 7115
- Pages
- 1045-1049
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2090221075
- Cited by
- 429
- References
- 31
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.